Search clinical trials for: Rinderon® - DP = betamethasone dipropionate
Total 542 results
-
Oncology Specialists, S.C.Millennium Pharmaceuticals, Inc.TerminatedLymphoma, B-Cell | Lymphoma, Non-HodgkinUnited States
-
SanofiRecruitingPlasma Cell Myeloma RefractoryFrance, Australia, Greece, Italy, Norway, United States, Portugal, Puerto Rico
-
Respirent Pharmaceuticals Co Ltd.Becro Ltd.Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.; Celgene CorporationActive, not recruitingMultiple Myeloma in RelapseUnited States
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.; CelgeneActive, not recruiting
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)Withdrawn
-
AmgenCompletedMultiple MyelomaCanada, Denmark, Finland, France, Italy, Spain, Sweden, United Kingdom, Czechia, Poland, United States, Belgium, Hungary, New Zealand, Australia, Germany, Japan, Greece, Norway, Romania
-
Carmen Schade-BrittingerCompleted
-
University Hospital, AntwerpChiesi Farmaceutici S.p.A.Completed
-
Emory UniversityNational Cancer Institute (NCI)Not yet recruitingMeningioma | Low Grade Glioma | Malignant Brain Neoplasm | Malignant Brain GliomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Not yet recruitingGlioblastoma | Malignant GliomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic LeukemiaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)WithdrawnStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Recurrent Lung Carcinoma | Stage IV Lung Cancer AJCC v8 | Lung Squamous Cell Carcinoma
-
Galderma R&DCompleted
-
University of WashingtonGenzyme, a Sanofi CompanyRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
M.D. Anderson Cancer CenterTakedaActive, not recruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedSquamous Cell CancerFrance, Italy, Spain, Germany, Hungary, Austria, Switzerland, Belgium, Poland
-
Alcon ResearchCompletedAcute Otitis MediaUnited States
-
Liverpool School of Tropical MedicineLondon School of Hygiene and Tropical Medicine; University of Bergen; Kamuzu... and other collaboratorsCompletedMalaria in Pregnancy | Adherence, TreatmentKenya
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic Obstructive
-
Wake Forest University Health SciencesCarolinas Trauma Network Research Group; Charlotte, Houston, Milwaukee Prehospital...Completed
-
St. Jude Children's Research HospitalPfizerTerminatedAcute Lymphoblastic Leukemia, in Relapse | Acute Lymphoblastic Leukemia With Failed RemissionUnited States
-
AbbVieCompleted
-
Ain Shams UniversityCompletedPost Operative Pain Control
-
St. Jude Children's Research HospitalNovartis Pharmaceuticals; Spectrum Pharmaceuticals, IncTerminatedAcute Lymphoblastic Leukemia | Leukemia, B-Cell | Leukemia, T-Cell | Lymphoma, Non-Hodgkin'sUnited States
-
GlaxoSmithKlineCompleted
-
Mundipharma Research LimitedCompletedAsthma BronchialeUnited Kingdom
-
Mundipharma Research LimitedCompletedAsthmaRomania, Hungary, Czechia, France, Germany, Poland
-
Andover Research Eye InstituteCompletedAllergic ConjunctivitisUnited States
-
Parc de Salut MarRecruiting
-
Rashmi Verma, MDNational Cancer Institute (NCI)RecruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Adenocarcinoma | Stage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v8United States
-
AmgenTerminated
-
M.D. Anderson Cancer CenterLeadiant Biosciences, Inc.CompletedLeukemia, Lymphocytic, AcuteUnited States
-
Swiss Group for Clinical Cancer ResearchTerminatedRefractory Multiple MyelomaSwitzerland
-
CelgeneCompleted
-
Abdullah KhanTerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Novartis PharmaceuticalsCompletedMultiple MyelomaChina, United States, Italy, Taiwan, Egypt, Japan, Turkey, Germany, Netherlands, Canada, Australia, Austria, Israel, Sweden, United Kingdom, Korea, Republic of, Spain, Hong Kong, Thailand, France, Belgium, Norway, South Africa, Brazil, ... and more
-
CelgeneCompletedMultiple MyelomaUnited States, Netherlands, Canada, Belgium, United Kingdom, Australia, Denmark, Germany, Spain, Switzerland, France, Italy, Greece, Russian Federation, Sweden, Czechia
-
St. Jude Children's Research HospitalAbbVieNot yet recruitingT-cell Lymphoma | T-cell Acute Lymphoblastic Leukemia | Mixed Phenotype Acute LeukemiaUnited States
-
Almirall, S.A.Completed
-
H. Lee Moffitt Cancer Center and Research InstituteCelgeneCompletedMultiple MyelomaUnited States
-
Columbia UniversityCephalonCompletedAL AmyloidosisUnited States
-
M.D. Anderson Cancer CenterEnzon Pharmaceuticals, Inc.CompletedAcute Lymphoblastic LeukemiaUnited States
-
Andrew E. Place, MDUniversity of Colorado, Denver; AbbVie; Boston Children's Hospital; Gateway for... and other collaboratorsRecruitingAcute Lymphoblastic Leukemia, in Relapse | Therapy-Related Myelodysplastic Syndrome | Acute Leukemia of Ambiguous Lineage | Acute Leukemia of Ambiguous Lineage in Relapse | Myelodysplastic Syndromes, Previously Treated | Acute Lymphoblastic Leukemia With Failed Remission | Myelodysplastic Syndromes... and other conditionsUnited States
-
Weill Medical College of Cornell UniversityOnyx Therapeutics, Inc.Active, not recruiting
-
National Cancer Institute (NCI)CompletedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCelgeneCompletedMyelomaUnited States
-
Nantes University HospitalCompleted